Megna Michael R

US insider· US
Sign in for alerts
HoldingsTimelineOverlapsAbout
  • ACQUIREDStale

    Kiniksa Pharmaceuticals Intl · NASDAQ

    +3,932 sh

    Filed 3 Sept 2026SEC Form 4view source
  • REDUCEDStale

    Kiniksa Pharmaceuticals Intl · NASDAQ

    −4,600 sh · $369.4K

    Filed 3 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Kiniksa Pharmaceuticals Intl · NASDAQ

    +2,362 sh

    Filed 3 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Kiniksa Pharmaceuticals Intl · NASDAQ

    +279 sh · $9.3K

    Filed 3 Sept 2026SEC Form 4view source
  • REDUCEDStale

    Kiniksa Pharmaceuticals Intl · NASDAQ

    −5,531 sh · $438.5K

    Filed 3 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Kiniksa Pharmaceuticals Intl · NASDAQ

    +2,558 sh

    Filed 3 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Kiniksa Pharmaceuticals Intl · NASDAQ

    +2,644 sh

    Filed 3 Sept 2026SEC Form 4view source